<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38474072</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Lumican, a Multifunctional Cell Instructive Biomarker Proteoglycan Has Novel Roles as a Marker of the Hypercoagulative State of Long Covid Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25052825</ELocationID><Abstract><AbstractText>This study has reviewed the many roles of lumican as a biomarker of tissue pathology in health and disease. Lumican is a structure regulatory proteoglycan of collagen-rich tissues, with cell instructive properties through interactions with a number of cell surface receptors in tissue repair, thereby regulating cell proliferation, differentiation, inflammation and the innate and humoral immune systems to combat infection. The exponential increase in publications in the last decade dealing with lumican testify to its role as a pleiotropic biomarker regulatory protein. Recent findings show lumican has novel roles as a biomarker of the hypercoagulative state that occurs in SARS CoV-2 infections; thus, it may also prove useful in the delineation of the complex tissue changes that characterize COVID-19 disease. Lumican may be useful as a prognostic and diagnostic biomarker of long COVID disease and its sequelae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Margaret M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-2020-0056</Identifier><AffiliationInfo><Affiliation>Raymond Purves Laboratory, Institute of Bone and Joint Research, Kolling Institute of Medical Research, Faculty of Health and Science, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arthropharm Pty Ltd., Bondi Junction, NSW 2022, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melrose</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9237-0524</Identifier><AffiliationInfo><Affiliation>Raymond Purves Laboratory, Institute of Bone and Joint Research, Kolling Institute of Medical Research, Faculty of Health and Science, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>n/a</GrantID><Agency>Melrose Personal Research Fund, Sydney, Australia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011509">Proteoglycans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071234">Lumican</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011508">Chondroitin Sulfate Proteoglycans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011509" MajorTopicYN="Y">Proteoglycans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071234" MajorTopicYN="N">Lumican</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011508" MajorTopicYN="N">Chondroitin Sulfate Proteoglycans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MMP inhibitor</Keyword><Keyword MajorTopicYN="N">anti-tumour</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">lumican</Keyword><Keyword MajorTopicYN="N">tissue pathology</Keyword></KeywordList><CoiStatement>The authors have no conflicts to report. JM has received consultancy fees from Arthropharm Pharmaceutical Company. MMS is clinical director of research for Arthropharm Pharmaceutical Company. This company had no input into the writing of this study, interpretation of data or the reason to publish this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38474072</ArticleId><ArticleId IdType="pmc">PMC10931941</ArticleId><ArticleId IdType="doi">10.3390/ijms25052825</ArticleId><ArticleId IdType="pii">ijms25052825</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raouf A., Ganss B., McMahon C., Vary C., Roughley P.J., Seth A. Lumican is a major proteoglycan component of the bone matrix. Matrix Biol. 2002;21:361&#x2013;367. doi: 10.1016/S0945-053X(02)00027-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0945-053X(02)00027-6</ArticleId><ArticleId IdType="pubmed">12128073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying S., Shiraishi A., Kao C.W.-C., Converse R.L., Funderburgh J.L., Swiergiel J., Roth M.R., Conrad G.W., Kao W.W.-Y. Characterization and Expression of the Mouse Lumican Gene. J. Biol. Chem. 1997;272:30306&#x2013;30313. doi: 10.1074/jbc.272.48.30306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.48.30306</ArticleId><ArticleId IdType="pubmed">9374517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti S., Paul J., Roberts L., Chervoneva I., Oldberg A., Birk D.E. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Investig. Ophthalmol. Vis. Sci. 2003;44:2422&#x2013;2432. doi: 10.1167/iovs.02-0783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.02-0783</ArticleId><ArticleId IdType="pubmed">12766039</ArticleId></ArticleIdList></Reference><Reference><Citation>Corpuz L., Funderburgh J.L., Funderburgh M.L., Bottomley G.S., Prakash S., Conrad G.W. Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J. Biol. Chem. 1996;271:9759&#x2013;9763. doi: 10.1074/jbc.271.16.9759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.16.9759</ArticleId><ArticleId IdType="pubmed">8621655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti S., Petroll W.M., Hassell J.R., Jester J., Lass J.H., Paul J., Birk D.E. Corneal opacity in lumican-null mice: Defects in collagen fibril structure and packing in the posterior stroma. Investig. Ophthalmol. Vis. Sci. 2000;41:3365&#x2013;3373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318236</ArticleId><ArticleId IdType="pubmed">11006226</ArticleId></ArticleIdList></Reference><Reference><Citation>Quantock A., Meek K., Chakravarti S. An X-ray diffraction investigation of corneal structure in lumican-deficient mice. Investig. Ophthalmol. Vis. Sci. 2001;42:1750&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pubmed">11431438</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wit M., Carvalho B., Diemen P.M.D.-V., Van Alphen C., Beli&#xeb;n J.A.M., Meijer G.A., Fijneman R.J.A. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression. PLoS ONE. 2017;12:e0174768. doi: 10.1371/journal.pone.0174768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174768</ArticleId><ArticleId IdType="pmc">PMC5421768</ArticleId><ArticleId IdType="pubmed">28481899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiwata T., Cho K., Kawahara K., Yamamoto T., Fujiwara Y., Uchida E., Tajiri T., Naito Z. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer. Oncol. Rep. 2007;18:537&#x2013;543. doi: 10.3892/or.18.3.537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.18.3.537</ArticleId><ArticleId IdType="pubmed">17671699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemen L., Couch F.J., Ahmed S., Dunning A.M., Pharoah P.D., Easton D.F., Fredericksen Z.S., Vierkant R.A., Pankratz V.S., Goode E.L., et al. Genetic variation in stromal proteins decorin and lumican with breast cancer: Investigations in two case-control studies. Breast Cancer Res. 2008;10:R98. doi: 10.1186/bcr2201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/bcr2201</ArticleId><ArticleId IdType="pmc">PMC2656894</ArticleId><ArticleId IdType="pubmed">19036156</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi N., Kanke Y., Saito K., Okayama H., Yamada S., Nakajima S., Endo E., Kase K., Yamada L., Nakano H., et al. Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma. Oncol. Lett. 2021;21:445. doi: 10.3892/ol.2021.12706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2021.12706</ArticleId><ArticleId IdType="pmc">PMC8045151</ArticleId><ArticleId IdType="pubmed">33868483</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda Y., Yamamoto T., Kudo M., Kawahara K., Kawamoto M., Nakajima Y., Koizumi K., Nakazawa N., Ishiwata T., Naito Z. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int. J. Oncol. 2008;33:1177&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">19020750</ArticleId></ArticleIdList></Reference><Reference><Citation>Appunni S., Rubens M., Ramamoorthy V., Anand V., Khandelwal M., Saxena A., McGranaghan P., Odia Y., Kotecha R., Sharma A. Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum. Clin. Chim. Acta. 2021;514:1&#x2013;7. doi: 10.1016/j.cca.2020.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.12.011</ArticleId><ArticleId IdType="pubmed">33333043</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S., Gao Y., Yin D., Lv L., Wen Y., Li Z., Wang B., Wu M., Liu B. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy. Kidney Blood Press. Res. 2021;46:275&#x2013;285. doi: 10.1159/000514013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514013</ArticleId><ArticleId IdType="pubmed">33887734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadzadeh N., Lunde I.G., Anden&#xe6;s K., Strand M.E., Aronsen J.M., Skrbic B., Marstein H.S., Bandlien C., Nyg&#xe5;rd S., Gorham J., et al. The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload. Sci. Rep. 2019;9:9206. doi: 10.1038/s41598-019-45651-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45651-9</ArticleId><ArticleId IdType="pmc">PMC6591256</ArticleId><ArticleId IdType="pubmed">31235849</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer L. Small leucine-rich proteoglycans in kidney disease. J. Am. Soc. Nephrol. 2011;22:1200&#x2013;1207. doi: 10.1681/ASN.2010050570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010050570</ArticleId><ArticleId IdType="pubmed">21719787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti S., Stallings R.L., SundarRaj N., Cornuet P.K., Hassell J.R. Primary structure of human lumican (Keratan Sulfate Proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics. 1995;27:481&#x2013;488. doi: 10.1006/geno.1995.1080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1995.1080</ArticleId><ArticleId IdType="pubmed">7558030</ArticleId></ArticleIdList></Reference><Reference><Citation>Iozzo R. The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 1997;32:141&#x2013;174. doi: 10.3109/10409239709108551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409239709108551</ArticleId><ArticleId IdType="pubmed">9145286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., LaMantia C., Carroll H. Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 1998;141:1277&#x2013;1286. doi: 10.1083/jcb.141.5.1277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.141.5.1277</ArticleId><ArticleId IdType="pmc">PMC2137175</ArticleId><ArticleId IdType="pubmed">9606218</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassot C., Briet M., Rostagno P., Barbry P., Perret C., Laude D., Boutouyrie P., Bozec E., Bruneva L.P., Latremouille C., et al. Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J. Hypertens. 2008;26:747&#x2013;757. doi: 10.1097/HJH.0b013e3282f4b3d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e3282f4b3d0</ArticleId><ArticleId IdType="pubmed">18327085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeltz C., Br&#xe9;zillon S., Perreau C., Ramont L., Maquart F.X., Wegrowski Y. Lumcorin: A leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration. FEBS Lett. 2009;583:3027&#x2013;3032. doi: 10.1016/j.febslet.2009.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.08.012</ArticleId><ArticleId IdType="pubmed">19686741</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe9;zillon S., Radwanska A., Zeltz C., Malkowski A., Ploton D., Bobichon H., Perreau C., Malicka-Blaszkiewicz M., Maquart F.X., Wegrowski Y. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett. 2009;283:92&#x2013;100. doi: 10.1016/j.canlet.2009.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2009.03.032</ArticleId><ArticleId IdType="pubmed">19394140</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe9;zillon S., Pietraszek K., Maquart F.X., Wegrowski Y. Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins. FEBS J. 2013;280:2369&#x2013;2381. doi: 10.1111/febs.12210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12210</ArticleId><ArticleId IdType="pubmed">23438179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesteira T., Coulson-Thomas V.J., Yuan Y., Zhang J., Nader H.B., Kao W.W. Lumican Peptides: Rational Design Targeting ALK5/TGFBRI. Sci. Rep. 2017;7:42057. doi: 10.1038/srep42057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42057</ArticleId><ArticleId IdType="pmc">PMC5299588</ArticleId><ArticleId IdType="pubmed">28181591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietraszek K., Chatron-Colliet A., Br&#xe9;zillon S., Perreau C., Jakubiak-Augustyn A., Krotkiewski H., Maquart F.X., Wegrowski Y. Lumican: A new inhibitor of matrix metalloproteinase-14 activity. FEBS Lett. 2014;588:4319&#x2013;4324. doi: 10.1016/j.febslet.2014.09.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.09.040</ArticleId><ArticleId IdType="pubmed">25304424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietraszek K., Br&#xe9;zillon S., Perreau C., Malicka-B&#x142;aszkiewicz M., Maquart F.X., Wegrowski Y. Lumican&#x2014;Derived peptides inhibit melanoma cell growth and migration. PLoS ONE. 2013;8:e76232. doi: 10.1371/journal.pone.0076232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076232</ArticleId><ArticleId IdType="pmc">PMC3788744</ArticleId><ArticleId IdType="pubmed">24098450</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H., Liu C., Ren Q., Zhang L., Qin W., Wang H., Zhang Y. The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. Pancreas. 2023;52:e29&#x2013;e36. doi: 10.1097/MPA.0000000000002211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPA.0000000000002211</ArticleId><ArticleId IdType="pubmed">37378898</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh Y., Sahni V., Shnider S.J., McKee H., Macklis J.D. Inter-axonal molecular crosstalk via Lumican proteoglycan sculpts murine cervical corticospinal innervation by distinct subpopulations. Cell Rep. 2023;42:112182. doi: 10.1016/j.celrep.2023.112182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112182</ArticleId><ArticleId IdType="pmc">PMC10167627</ArticleId><ArticleId IdType="pubmed">36934325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H., Lee Y.S., Kim D.A., Moon S.A., Lee S.E., Lee S.H., Koh J.M. Lumican, an Exerkine, Protects against Skeletal Muscle Loss. Int. J. Mol. Sci. 2022;23:10031. doi: 10.3390/ijms231710031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231710031</ArticleId><ArticleId IdType="pmc">PMC9456076</ArticleId><ArticleId IdType="pubmed">36077426</ArticleId></ArticleIdList></Reference><Reference><Citation>Iozzo R.S.L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11&#x2013;55. doi: 10.1016/j.matbio.2015.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2015.02.003</ArticleId><ArticleId IdType="pmc">PMC4859157</ArticleId><ArticleId IdType="pubmed">25701227</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitovic D., Papoutsidakis A., Karamanos N., Tzanakakis G. Lumican affects tumor cell functions, tumor&#x2013;ECM interactions, angiogenesis and inflammatory response. Matrix Biol. 2014;35:206&#x2013;214. doi: 10.1016/j.matbio.2013.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2013.09.003</ArticleId><ArticleId IdType="pubmed">24060754</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzanakakis G., Giatagana E.-M., Kuskov A., Berdiaki A., Tsatsakis A., Neagu M., Nikitovic D. Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors. Cancers. 2020;12:2401. doi: 10.3390/cancers12092401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12092401</ArticleId><ArticleId IdType="pmc">PMC7563227</ArticleId><ArticleId IdType="pubmed">32847060</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzanakakis G., Giatagana E.-M., Berdiaki A., Spyridaki I., Hida K., Neagu M., Tsatsakis A., Nikitovic D. The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis. Cancers. 2021;13:2478. doi: 10.3390/cancers13102478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13102478</ArticleId><ArticleId IdType="pmc">PMC8160938</ArticleId><ArticleId IdType="pubmed">34069554</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggelidakis J., Berdiaki A., Nikitovic D., Papoutsidakis A., Papachristou D.J., Tsatsakis A.M., Tzanakakis G.N. Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/beta-Catenin/IGFR-IR Signaling Axis. Front. Oncol. 2018;8:470. doi: 10.3389/fonc.2018.00470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00470</ArticleId><ArticleId IdType="pmc">PMC6206209</ArticleId><ArticleId IdType="pubmed">30406034</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoutsidakis A., Giatagana E.M., Berdiaki A., Spyridaki I., Spandidos D.A., Tsatsakis A., Tzanakakis G.N., Nikitovic D. Lumican mediates HTB94 chondrosarcoma cell growth via an IGFIR/Erk1/2 axis. Int. J. Oncol. 2020;57:791&#x2013;803. doi: 10.3892/ijo.2020.5094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2020.5094</ArticleId><ArticleId IdType="pmc">PMC7384848</ArticleId><ArticleId IdType="pubmed">32705211</ArticleId></ArticleIdList></Reference><Reference><Citation>Voudouri K., Nikitovic D., Berdiaki A., Kletsas D., Karamanos N., Tzanakakis G.N. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion. Matrix Biol. 2016;56:95&#x2013;113. doi: 10.1016/j.matbio.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2016.06.005</ArticleId><ArticleId IdType="pubmed">27353258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafiropoulos A., Nikitovic D., Katonis P., Tsatsakis A., Karamanos N.K., Tzanakakis G.N. Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells. Mol. Cancer Res. 2008;6:785&#x2013;794. doi: 10.1158/1541-7786.MCR-07-0165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-07-0165</ArticleId><ArticleId IdType="pubmed">18505923</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti G., Ashworth S., Choi T., Chakravarti S. Molecular cues for immune cells from small leucine-rich repeat proteoglycans in their extracellular matrix-associated and free forms. Matrix Biol. 2023;123:48&#x2013;58. doi: 10.1016/j.matbio.2023.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2023.10.001</ArticleId><ArticleId IdType="pmc">PMC10841460</ArticleId><ArticleId IdType="pubmed">37793508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng-Brouwers J., Pandey S., Trebicka J., Wygrecka M., Schaefer L. Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases. J. Histochem. Cytochem. 2020;68:887&#x2013;906. doi: 10.1369/0022155420930303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155420930303</ArticleId><ArticleId IdType="pmc">PMC7708667</ArticleId><ArticleId IdType="pubmed">32623933</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey H., Schroeder N., Manon-Jensen T., Iozzo R.V., Schaefer L. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 2013;280:2165&#x2013;2179. doi: 10.1111/febs.12145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12145</ArticleId><ArticleId IdType="pmc">PMC3651745</ArticleId><ArticleId IdType="pubmed">23350913</ArticleId></ArticleIdList></Reference><Reference><Citation>Engebretsen K., Lunde I.G., Strand M.E., Waehre A., Sjaastad I., Marstein H.S., Skrbic B., Dahl C.P., Askevold E.T., Christensen G., et al. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. FEBS J. 2013;280:2382&#x2013;2398. doi: 10.1111/febs.12235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12235</ArticleId><ArticleId IdType="pubmed">23480731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Cui S., Ding Y., Li Y., Wu B., Gao J., Li M., Xu L., Xia H. Downregulation of B4GALT5 attenuates cardiac fibrosis through Lumican and Akt/GSK-3&#x3b2;/&#x3b2;-catenin pathway. Eur. J. Pharmacol. 2023;9:176263. doi: 10.1016/j.ejphar.2023.176263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2023.176263</ArticleId><ArticleId IdType="pubmed">38081351</ArticleId></ArticleIdList></Reference><Reference><Citation>Rixon C., Andreassen K., Shen X., Erusappan P.M., Almaas V.M., Palmero S., Dahl C.P., Ueland T., Sjaastad I., Louch W.E., et al. Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy. ESC Heart Fail. 2023;10:858&#x2013;871. doi: 10.1002/ehf2.14234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14234</ArticleId><ArticleId IdType="pmc">PMC10053290</ArticleId><ArticleId IdType="pubmed">36444917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukoglu O., Sowa J.-P., Mazzolini G.D., Syn W.-K., Canbay A. Hepatokines and adipokines in nash-related hepatocellular carcinoma. J. Hepatol. 2021;74:442&#x2013;457. doi: 10.1016/j.jhep.2020.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.10.030</ArticleId><ArticleId IdType="pubmed">33161047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray F., Ferlay J., Soerjomataram I., Siegel R., Torre L.A., Jemal A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394&#x2013;424. doi: 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Li Z., Wu Q., Liu H., Sun Z., Wu Y., Luo J. B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma. BMC Cancer. 2022;22:392. doi: 10.1186/s12885-022-09442-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-022-09442-2</ArticleId><ArticleId IdType="pmc">PMC9004124</ArticleId><ArticleId IdType="pubmed">35410157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun Y., Obeid L.M. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 2018;19:175&#x2013;191. doi: 10.1038/nrm.2017.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.107</ArticleId><ArticleId IdType="pmc">PMC5902181</ArticleId><ArticleId IdType="pubmed">29165427</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.-F., Zhu C.-S., Wang Y.-M., Xie X.-X., Xiao L.-L., Zhang Z.-C., Tang Q.-Q., Li X. Downregulation of &#x3b2;1, 4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation. Cell Death Dis. 2018;9:196. doi: 10.1038/s41419-017-0239-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0239-5</ArticleId><ArticleId IdType="pmc">PMC5833706</ArticleId><ArticleId IdType="pubmed">29415997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W., Li M., Qi X., Li J. &#x3b2;1, 4-galactosyltransferase v modulates breast cancer stem cells through wnt/&#x3b2;-catenin signaling pathway. Cancer Res. Treat Off. J. Korean Cancer Assoc. 2020;52:1084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577798</ArticleId><ArticleId IdType="pubmed">32599982</ArticleId></ArticleIdList></Reference><Reference><Citation>Coats C., Heywood W.E., Virasami A., Ashrafi N., Syrris P., Dos Remedios C., Treibel T.A., Moon J.C., Lopes L.R., McGregor C.G.A., et al. Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy. Circ. Genom. Precis. Med. 2018;11:e001974. doi: 10.1161/CIRCGENETICS.117.001974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.117.001974</ArticleId><ArticleId IdType="pubmed">30562113</ArticleId></ArticleIdList></Reference><Reference><Citation>Das T., Prodhan C., Patsa S., Ray J.G., Chaudhuri K. Identification of over expressed proteins in oral submucous fibrosis by proteomic analysis. J. Cell Biochem. 2018;119:4361&#x2013;4371. doi: 10.1002/jcb.26423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26423</ArticleId><ArticleId IdType="pubmed">28980718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Tu T., Gao Z., Wu X., Wang W., Liu W. Impaired collagen fibril assembly in keloids with enhanced expression of lumican and collagen V. Arch. Biochem. Biophys. 2021;697:108676. doi: 10.1016/j.abb.2020.108676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2020.108676</ArticleId><ArticleId IdType="pubmed">33188736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Li X., Xu X., He Z., Cui L., Lv X. Lumican alleviates hypertrophic scarring by suppressing integrin-FAK signaling. Biochem. Biophys. Res. Commun. 2016;480:153&#x2013;159. doi: 10.1016/j.bbrc.2016.09.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.159</ArticleId><ArticleId IdType="pubmed">27693693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M., Morin J., Roughley P.J., Ludwig M.S. Expression of lumican in human lungs. Am. J. Respir. Cell Mol. Biol. 1998;19:582&#x2013;587. doi: 10.1165/ajrcmb.19.4.2979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.19.4.2979</ArticleId><ArticleId IdType="pubmed">9761754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Wang Y., Cao Y., Wang H., Zhou Y., Gao L., Zeng Z., Cheng M., Jin X., Chen J., et al. Lumican is elevated in the lung in human and experimental acute respiratory distress syndrome and promotes early fibrotic responses to lung injury. J. Transl. Med. 2022;20:392. doi: 10.1186/s12967-022-03597-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03597-z</ArticleId><ArticleId IdType="pmc">PMC9440861</ArticleId><ArticleId IdType="pubmed">36059026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilling D., Vakil V., Cox N., Gomer R.H. TNF-&#x3b1;-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation. Proc. Natl. Acad. Sci. USA. 2015;112:11929&#x2013;11934. doi: 10.1073/pnas.1507387112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1507387112</ArticleId><ArticleId IdType="pmc">PMC4586854</ArticleId><ArticleId IdType="pubmed">26351669</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgstaller G., Oehrle B., Gerckens M., White E.S., Schiller H.B., Eickelberg O. The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. Eur. Respir. J. 2017;50:1601805. doi: 10.1183/13993003.01805-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01805-2016</ArticleId><ArticleId IdType="pubmed">28679607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y., Kao W.W., Yeh Y.H., Chen W.J., Chu P.H. Lumican deficiency promotes pulmonary arterial remodeling. Transl. Res. 2021;237:63&#x2013;81. doi: 10.1016/j.trsl.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.05.007</ArticleId><ArticleId IdType="pubmed">34091085</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin B.J.H., Kakamad F.H., Ahmed G.S., Ahmed S.F., Abdulla B.A., Mikael T.M., Salih R.Q., Salh A.M., Hussein D.A. Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann. Med. Surg. 2022;77:103590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983072</ArticleId><ArticleId IdType="pubmed">35411216</ArticleId></ArticleIdList></Reference><Reference><Citation>Long K., Newland B., Florio M., Kalebic N., Langen B., Kolterer A., Wimberger P., Huttner W.B. Extracellular Matrix Components HAPLN1, Lumican, and Collagen I Cause Hyaluronic Acid-Dependent Folding of the Developing Human Neocortex. Neuron. 2018;99:702&#x2013;719.e6. doi: 10.1016/j.neuron.2018.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.07.013</ArticleId><ArticleId IdType="pubmed">30078576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb J., Tsata V., John N., Kim K., M&#xf6;ckel C., Rosso G., Kurbel V., Parmar A., Sharma G., Karandasheva K., et al. Small leucine-rich proteoglycans inhibit CNS regeneration by modifying the structural and mechanical properties of the lesion environment. Nat. Commun. 2023;14:6814. doi: 10.1038/s41467-023-42339-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-42339-7</ArticleId><ArticleId IdType="pmc">PMC10603094</ArticleId><ArticleId IdType="pubmed">37884489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhrira N., DeOre B.J., Tran K.A., Galie P.A. Transcriptomic analysis of a 3D blood-brain barrier model exposed to disturbed fluid flow. Fluids Barriers CNS. 2022;19:94. doi: 10.1186/s12987-022-00389-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00389-x</ArticleId><ArticleId IdType="pmc">PMC9700938</ArticleId><ArticleId IdType="pubmed">36434717</ArticleId></ArticleIdList></Reference><Reference><Citation>Friden V., Oveland E., Tenstad O., Ebefors K., Nystrom J., Nilsson U.A., Haraldsson B. The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int. 2011;79:1322&#x2013;1330. doi: 10.1038/ki.2011.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.58</ArticleId><ArticleId IdType="pubmed">21412215</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues-Amorim D., Rivera-Baltan&#xe1;s T., Fern&#xe1;ndez-Palleiro P., Iglesias-Mart&#xed;nez-Almeida M., Freir&#xed;a-Mart&#xed;nez L., Jarmardo-Rodriguez C., Del Carmen Vallejo-Curto M., &#xc1;lvarez-Ariza M., L&#xf3;pez-Garc&#xed;a M., De Las Heras E., et al. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target. Cell. Mol. Neurobiol. 2022;42:1921&#x2013;1932. doi: 10.1007/s10571-021-01073-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-021-01073-8</ArticleId><ArticleId IdType="pubmed">33712885</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A., Hu D., George S.Z., Schwartz T.A., Kraus V.B., Huebner J.L., Cleveland R.J., Taylor K.A., Jordan J.M., Golightly Y.M. Biomarker clusters differentiate phenotypes of lumbar spine degeneration and low back pain: The Johnston County Osteoarthritis Project. Osteoarthr. Cartil. Open. 2022;4:100270. doi: 10.1016/j.ocarto.2022.100270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ocarto.2022.100270</ArticleId><ArticleId IdType="pmc">PMC9387345</ArticleId><ArticleId IdType="pubmed">35991624</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A., Cleveland R.J., Kraus V.B., Taylor K.A., George S.Z., Schwartz T.A., Renner J., Huebner J.L., Jordan J.M., Golightly Y.M. Biomarkers and longitudinal changes in lumbar spine degeneration and low back pain: The Johnston County Osteoarthritis Project. Osteoarthr. Cartil. 2023;31:809&#x2013;818. doi: 10.1016/j.joca.2023.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2023.02.005</ArticleId><ArticleId IdType="pmc">PMC10200763</ArticleId><ArticleId IdType="pubmed">36804589</ArticleId></ArticleIdList></Reference><Reference><Citation>Djuric N., Rajasekaran S., Tangavel C., Raveendran M., Soundararajan D.C.R., Nayagam S.M., Matchado M.S., Anand K.S.S.V., Shetty A.P., Kanna R.M. Influence of endplate avulsion and Modic changes on the inflammation profile of herniated discs: A proteomic and bioinformatic approach. Eur. Spine J. 2022;31:389&#x2013;399. doi: 10.1007/s00586-021-06989-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-021-06989-9</ArticleId><ArticleId IdType="pubmed">34611718</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Sun C., Chen M., Wang B. Lumican silencing alleviates tumor necrosis factor-&#x3b1;-induced nucleus pulposus cell inflammation and senescence by inhibiting apoptosis signal regulating kinase 1/p38 signaling pathway via inactivating Fas ligand expression. Bioengineered. 2021;12:6891&#x2013;6901. doi: 10.1080/21655979.2021.1973781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1973781</ArticleId><ArticleId IdType="pmc">PMC8806543</ArticleId><ArticleId IdType="pubmed">34516336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Kim D.A., Kim E.Y., Chang E.J., Park S.J., Kim B.J. Lumican Inhibits Osteoclastogenesis and Bone Resorption by Suppressing Akt Activity. Int. J. Mol. Sci. 2021;22:4717. doi: 10.3390/ijms22094717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094717</ArticleId><ArticleId IdType="pmc">PMC8124849</ArticleId><ArticleId IdType="pubmed">33946862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rada J.A., Cornuet P.K., Hassell J.R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp. Eye Res. 1993;56:635&#x2013;648. doi: 10.1006/exer.1993.1081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exer.1993.1081</ArticleId><ArticleId IdType="pubmed">8595806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezura Y., Chakravarti S., Oldberg A., Chervoneva I., Birk D.E. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol. 2000;151:779&#x2013;788. doi: 10.1083/jcb.151.4.779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.151.4.779</ArticleId><ArticleId IdType="pmc">PMC2169450</ArticleId><ArticleId IdType="pubmed">11076963</ArticleId></ArticleIdList></Reference><Reference><Citation>Giatagana E., Berdiaki A., Tsatsakis A., Tzanakakis G.N., Nikitovic D. Lumican in Carcinogenesis-Revisited. Biomolecules. 2021;11:1319. doi: 10.3390/biom11091319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11091319</ArticleId><ArticleId IdType="pmc">PMC8466546</ArticleId><ArticleId IdType="pubmed">34572532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao K., Chu P.Y., Chang G.C., Liu K.J. Elevated Expression of Lumican in Lung Cancer Cells Promotes Bone Metastasis through an Autocrine Regulatory Mechanism. Cancers. 2020;12:233. doi: 10.3390/cancers12010233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12010233</ArticleId><ArticleId IdType="pmc">PMC7016828</ArticleId><ArticleId IdType="pubmed">31963522</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Li X., Hu X., Jiang F., Shen Y., Xu R., Wu L., Wei P., Shen X. LUM Expression and Its Prognostic Significance in Gastric Cancer. Front. Oncol. 2020;10:605. doi: 10.3389/fonc.2020.00605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.00605</ArticleId><ArticleId IdType="pmc">PMC7242722</ArticleId><ArticleId IdType="pubmed">32500021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhou Q., Yu Z., Wu X., Chen X., Li J., Li C., Yan M., Zhu Z., Liu B., et al. Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin &#x3b2;1-FAK signaling pathway. Int. J. Cancer. 2017;141:998&#x2013;1010. doi: 10.1002/ijc.30801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30801</ArticleId><ArticleId IdType="pubmed">28542982</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhovskih A., Aidagulova S.V., Kashuba V.I., Grigorieva E.V. Proteoglycans as potential microenvironmental biomarkers for colon cancer. Cell Tissue Res. 2015;361:833&#x2013;844. doi: 10.1007/s00441-015-2141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-015-2141-8</ArticleId><ArticleId IdType="pubmed">25715761</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Truty M.A., Kang Y., Chopin-Laly X., Zhang R., Roife D., Chatterjee D., Lin E., Thomas R.M., Wang H., et al. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin. Cancer Res. 2014;20:6529&#x2013;6540. doi: 10.1158/1078-0432.CCR-14-0970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-14-0970</ArticleId><ArticleId IdType="pmc">PMC4268437</ArticleId><ArticleId IdType="pubmed">25336691</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T., Matsuda Y., Kawahara K., Ishiwata T., Naito Z. Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer Lett. 2012;320:31&#x2013;39. doi: 10.1016/j.canlet.2012.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2012.01.023</ArticleId><ArticleId IdType="pubmed">22266188</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M., Boncela J., Perreau C., Karamanou K., Chatron-Colliet A., Proult I., Przygodzka P., Chakravarti S., Maquart F.X., Kowalska M.A., et al. Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity. PLoS ONE. 2016;11:e0150226. doi: 10.1371/journal.pone.0150226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150226</ArticleId><ArticleId IdType="pmc">PMC4773148</ArticleId><ArticleId IdType="pubmed">26930497</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauv&#xe9; J., Belloy N., Rivet R., Etique N., Nizet P., Pietraszek-Gremplewicz K., Karamanou K., Dauchez M., Ramont L., Br&#xe9;zillon S., et al. Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach. Cancers. 2021;13:4930. doi: 10.3390/cancers13194930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13194930</ArticleId><ArticleId IdType="pmc">PMC8507859</ArticleId><ArticleId IdType="pubmed">34638415</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe9;zillon S., Venteo L., Ramont L., D&#x2019;Onofrio M.F., Perreau C., Pluot M., Maquart F.X., Wegrowski Y. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin. Exp. Dermatol. 2007;32:405&#x2013;416. doi: 10.1111/j.1365-2230.2007.02437.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2230.2007.02437.x</ArticleId><ArticleId IdType="pubmed">17490399</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuillermoz B., Khoruzhenko A., D&#x2019;Onofrio M.F., Ramont L., Venteo L., Perreau C., Antonicelli F., Maquart F.X., Wegrowski Y. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 2004;296:294&#x2013;306. doi: 10.1016/j.yexcr.2004.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.02.005</ArticleId><ArticleId IdType="pubmed">15149859</ArticleId></ArticleIdList></Reference><Reference><Citation>Brezillon S., Zeltz C., Schneider L., Terryn C., Vuillermoz B., Ramont L., Perrau C., Pluot M., Diebold M.D., Radwanska A., et al. Lumican inhibits B16F1 melanoma cell lung metastasis. J. Physiol. Pharmacol. 2009;60((Suppl. S4)):15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20083847</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulson-Thomas V., Coulson-Thomas Y.M., Gesteira T.F., Andrade de Paula C.A., Carneiro C.R., Ortiz V., Toma L., Kao W.W., Nader H.B. Lumican expression, localization and antitumor activity in prostate cancer. Exp. Cell Res. 2013;319:967&#x2013;981. doi: 10.1016/j.yexcr.2013.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2013.01.023</ArticleId><ArticleId IdType="pmc">PMC3633477</ArticleId><ArticleId IdType="pubmed">23399832</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamanou K., Franchi M., Vynios D., Br&#xe9;zillon S. Semin Cancer Biology. Elsevier; Amsterdam, The Netherlands: 2020. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator; pp. 125&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">31401293</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke F., Johnson J., Kern S., Bennett C., Lourdusamy A., Lea D., Clifford S., Merry C., Stolnik S., Alexander M., et al. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging. Acta Neuropathol. Commun. 2023;11:6. doi: 10.1186/s40478-022-01496-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01496-4</ArticleId><ArticleId IdType="pmc">PMC9835248</ArticleId><ArticleId IdType="pubmed">36631900</ArticleId></ArticleIdList></Reference><Reference><Citation>Low S., Connor T.B., Kassem I.S., Costakos D.M., Chaurasia S.S. Small Leucine-Rich Proteoglycans (SLRPs) in the Retina. Int. J. Mol. Sci. 2021;22:7293. doi: 10.3390/ijms22147293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147293</ArticleId><ArticleId IdType="pmc">PMC8305803</ArticleId><ArticleId IdType="pubmed">34298915</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan T., Clark S.J., Unwin R.D., Ridge L.A., Day A.J., Bishop P.N. Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera. Investig. Ophthalmol. Vis. Sci. 2012;53:7528&#x2013;7538. doi: 10.1167/iovs.12-10797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.12-10797</ArticleId><ArticleId IdType="pmc">PMC3493184</ArticleId><ArticleId IdType="pubmed">23074202</ArticleId></ArticleIdList></Reference><Reference><Citation>Amjadi S., Mai K., McCluskey P., Wakefield D. The role of lumican in ocular disease. ISRN Ophthalmol. 2013;2013:632302. doi: 10.1155/2013/632302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/632302</ArticleId><ArticleId IdType="pmc">PMC3914189</ArticleId><ArticleId IdType="pubmed">24558602</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W., Lee C.H., Chiou S.H., Liao C.C., Cheng C.W. Aqueous Lumican Correlates with Central Retinal Thickness in Patients with Idiopathic Epiretinal Membrane: A Proteome Study. Dis. Markers. 2022;2022:9886846. doi: 10.1155/2022/9886846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9886846</ArticleId><ArticleId IdType="pmc">PMC9106516</ArticleId><ArticleId IdType="pubmed">35571611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Birk D.E. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J. 2013;280:2120&#x2013;2137. doi: 10.1111/febs.12136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12136</ArticleId><ArticleId IdType="pmc">PMC3651807</ArticleId><ArticleId IdType="pubmed">23331954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui M.-C., Liu H.-Y., Chu H.-S., Chen W.-L., Hu F.-R., Kao W.W.-Y., Wang I.-J. The versatile roles of lumican in eye diseases: A review. Ocul. Surf. 2023;29:388&#x2013;397. doi: 10.1016/j.jtos.2023.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtos.2023.06.012</ArticleId><ArticleId IdType="pubmed">37327869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Q., Han X., Bai D., Li D., Tian Y. Proteoglycans in the periodontium: A review with emphasis on specific distributions, functions, and potential applications. J. Periodontal Res. 2021;56:617&#x2013;632. doi: 10.1111/jre.12847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12847</ArticleId><ArticleId IdType="pubmed">33458817</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson S., Larjava H., H&#xe4;kkinen L. Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues. J. Periodontal Res. 2005;40:312&#x2013;324. doi: 10.1111/j.1600-0765.2005.00800.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0765.2005.00800.x</ArticleId><ArticleId IdType="pubmed">15966909</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall R., Embery G., Lloyd D. Immunochemical localization of the small leucine-rich proteoglycan lumican in human predentine and dentine. Arch. Oral. Biol. 1997;42:783&#x2013;786. doi: 10.1016/S0003-9969(97)00024-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-9969(97)00024-1</ArticleId><ArticleId IdType="pubmed">9447269</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores M., Hasegawa M., Yamato M., Takagi R., Okano T., Ishikawa I. Cementum-periodontal ligament complex regeneration using the cell sheet technique. J. Periodontal. Res. 2008;43:364&#x2013;371. doi: 10.1111/j.1600-0765.2007.01046.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0765.2007.01046.x</ArticleId><ArticleId IdType="pubmed">18205734</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito M., Tsuji T. Extracellular matrix administration as a potential therapeutic strategy for periodontal ligament regeneration. Expert. Opin. Biol. Ther. 2012;12:299&#x2013;309. doi: 10.1517/14712598.2012.655267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.2012.655267</ArticleId><ArticleId IdType="pubmed">22276595</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;low R., Boor P. Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold. J. Histochem. Cytochem. 2019;67:643&#x2013;661. doi: 10.1369/0022155419849388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155419849388</ArticleId><ArticleId IdType="pmc">PMC6713975</ArticleId><ArticleId IdType="pubmed">31116062</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese F., Manresa A.A., Leeming D.J., Karsdal M.A., Boor P. The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis Tissue Repair. 2014;7:4. doi: 10.1186/1755-1536-7-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-7-4</ArticleId><ArticleId IdType="pmc">PMC3986639</ArticleId><ArticleId IdType="pubmed">24678881</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan A., Li X., Kao W.Y., Viker K., Butters K., Masuoka H., Knudsen B., Gores G., Charlton M. Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab. Investig. 2012;92:1712&#x2013;1725. doi: 10.1038/labinvest.2012.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2012.121</ArticleId><ArticleId IdType="pmc">PMC3810270</ArticleId><ArticleId IdType="pubmed">23007134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nastase M., Janicova A., Roedig H., Hsieh L.T., Wygrecka M., Schaefer L. Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin. J. Histochem. Cytochem. 2018;66:261&#x2013;272. doi: 10.1369/0022155417738752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155417738752</ArticleId><ArticleId IdType="pmc">PMC5958374</ArticleId><ArticleId IdType="pubmed">29290137</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer L., Gr&#xf6;ne H.J., Raslik I., Robenek H., Ugorcakova J., Budny S., Schaefer R.M., Kresse H. Small proteoglycans of normal adult human kidney: Distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int. 2000;58:1557&#x2013;1568. doi: 10.1046/j.1523-1755.2000.00317.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2000.00317.x</ArticleId><ArticleId IdType="pubmed">11012890</ArticleId></ArticleIdList></Reference><Reference><Citation>Soylemezoglu O., Wild G., Dalley A.J., MacNeil S., Milford Ward A., Brown C.B., el Nahas A.M. Urinary and serum type III collagen: Markers of renal fibrosis. Nephrol. Dial. Transpl. 1997;12:1883&#x2013;1889. doi: 10.1093/ndt/12.9.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/12.9.1883</ArticleId><ArticleId IdType="pubmed">9306339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Mauer S.M., Kim Y., Michael A.F. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 1993;44:774&#x2013;788. doi: 10.1038/ki.1993.312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1993.312</ArticleId><ArticleId IdType="pubmed">8258955</ArticleId></ArticleIdList></Reference><Reference><Citation>Colon-Caraballo M., Lee N., Nallasamy S., Myers K., Hudson D., Iozzo R.V., Mahendroo M. Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy. Matrix Biol. 2022;105:53&#x2013;71. doi: 10.1016/j.matbio.2021.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2021.11.004</ArticleId><ArticleId IdType="pmc">PMC9446484</ArticleId><ArticleId IdType="pubmed">34863915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedem A., Ulanenko-Shenkar K., Yung Y., Youngster M., Avraham S., Yerushalmi G.M., Hourvitz A. The Involvement of Lumican in Human Ovulatory Processes. Reprod. Sci. 2022;29:366&#x2013;373. doi: 10.1007/s43032-021-00650-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-021-00650-y</ArticleId><ArticleId IdType="pubmed">34240328</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Hu Y., Wang Z., Pan H., Ren Y., Li X., Liu Z., Gao H. The Downregulation of Placental Lumican Promotes the Progression of Preeclampsia. Reprod. Sci. 2021;28:3147&#x2013;3154. doi: 10.1007/s43032-021-00660-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-021-00660-w</ArticleId><ArticleId IdType="pmc">PMC8526455</ArticleId><ArticleId IdType="pubmed">34231169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es R., Soares J.M., Jr., Sim&#xf5;es M.J., Nader H.B., Baracat M.C.P., Maciel G.A.R., Serafini P.C., Azziz R., Baracat E.C. Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: A pilot study. J. Ovarian Res. 2017;10:54. doi: 10.1186/s13048-017-0349-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13048-017-0349-9</ArticleId><ArticleId IdType="pmc">PMC5549392</ArticleId><ArticleId IdType="pubmed">28789706</ArticleId></ArticleIdList></Reference><Reference><Citation>Salgado R., Favaro R.R., Zorn T.M. Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Reprod. Biol. Endocrinol. 2011;9:22. doi: 10.1186/1477-7827-9-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7827-9-22</ArticleId><ArticleId IdType="pmc">PMC3041739</ArticleId><ArticleId IdType="pubmed">21294898</ArticleId></ArticleIdList></Reference><Reference><Citation>Salgado R., Favaro R.R., Martin S.S., Zorn T.M. The estrous cycle modulates small leucine-rich proteoglycans expression in mouse uterine tissues. Anat. Rec. 2009;292:138&#x2013;153. doi: 10.1002/ar.20797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.20797</ArticleId><ArticleId IdType="pubmed">18951514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucariello A., Trabucco E., Boccia O., Perna A., Sellitto C., Castaldi M.A., De Falco M., De Luca A., Cobellis L. Small leucine rich proteoglycans are differently distributed in normal and pathological endometrium. In Vivo. 2015;29:217&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">25792648</ArticleId></ArticleIdList></Reference><Reference><Citation>San Martin S., Soto-Suazo M., De Oliveira S.F., Aplin J.D., Abrahamsohn P., Zorn T.M. Small leucine-rich proteoglycans (SLRPs) in uterine tissues during pregnancy in mice. Reproduction. 2003;125:585&#x2013;595. doi: 10.1530/rep.0.1250585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/rep.0.1250585</ArticleId><ArticleId IdType="pubmed">12683929</ArticleId></ArticleIdList></Reference><Reference><Citation>Strieder-Barboza C., Flesher C.G., Geletka L.M., Eichler T., Akinleye O., Ky A., Ehlers A.P., Lumeng C.N., O&#x2019;Rourke R.W. Lumican modulates adipocyte function in obesity-associated type 2 diabetes. Adipocyte. 2022;11:665&#x2013;675. doi: 10.1080/21623945.2022.2154112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21623945.2022.2154112</ArticleId><ArticleId IdType="pmc">PMC9728465</ArticleId><ArticleId IdType="pubmed">36457256</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n-Ruiz R., Tercero-Alc&#xe1;zar C., Rabanal-Ruiz Y., D&#xed;az-Ruiz A., El Bekay R., Rangel-Zu&#xf1;iga O.A., Navarro-Ruiz M.C., Molero L., Membrives A., Ruiz-Rabelo J.F., et al. Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals. FASEB J. 2020;34:7520&#x2013;7539. doi: 10.1096/fj.201902703R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902703R</ArticleId><ArticleId IdType="pmc">PMC7384030</ArticleId><ArticleId IdType="pubmed">32293066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G., Taranko A.E., Meln I., Weinmann J., Sijmonsma T., Lerch S., Heide D., Billeter A.T., Tews D., Krunic D., et al. Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis. Mol. Metab. 2019;19:97&#x2013;106. doi: 10.1016/j.molmet.2018.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2018.10.007</ArticleId><ArticleId IdType="pmc">PMC6323191</ArticleId><ArticleId IdType="pubmed">30409703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirankaya A., Tugrul S., Ozcan S., Ince O., Donmez E., Atici A., Hancioglu E., Okuyan E., Sahin I. Correlation between the serum lumican level and the severity of coronary artery disease. Eur. Rev. Med. Pharmacol. Sci. 2023;27:2350&#x2013;2357.</Citation><ArticleIdList><ArticleId IdType="pubmed">37013754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Wu Q.H., Li Y., Gao P.J. Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. J. Hum. Hypertens. 2018;32:564&#x2013;571. doi: 10.1038/s41371-018-0077-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-018-0077-7</ArticleId><ArticleId IdType="pubmed">29867136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansmeier N., Buttigieg J., Kumar P., Pelle S., Choi K.Y., Kopriva D., Chao T.C. Identification of Mature Atherosclerotic Plaque Proteome Signatures Using Data-Independent Acquisition Mass Spectrometry. J. Proteome Res. 2018;17:164&#x2013;176. doi: 10.1021/acs.jproteome.7b00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.7b00487</ArticleId><ArticleId IdType="pubmed">29129081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu G., Cheng W., Yao C., Yin J., Tong C., Rao A., Yen L., Ku M., Rao J. Quantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissection. J. Biomed. Biotechnol. 2011;2011:920763. doi: 10.1155/2011/920763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/920763</ArticleId><ArticleId IdType="pmc">PMC3250623</ArticleId><ArticleId IdType="pubmed">22228989</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z., Xue Y., Yao C., Gu G., Zhang Y., Zhang J., Fan F., Luan X., Deng Z., Tao Z., et al. Acute Aortic Dissection Biomarkers Identified Using Isobaric Tags for Relative and Absolute Quantitation. Biomed. Res. Int. 2016;2016:6421451. doi: 10.1155/2016/6421451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6421451</ArticleId><ArticleId IdType="pmc">PMC4925974</ArticleId><ArticleId IdType="pubmed">27403433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultg&#xe5;rdh-Nilsson A., Bor&#xe9;n J., Chakravarti S. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. J. Intern. Med. 2015;278:447&#x2013;461. doi: 10.1111/joim.12400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12400</ArticleId><ArticleId IdType="pmc">PMC4616156</ArticleId><ArticleId IdType="pubmed">26477596</ArticleId></ArticleIdList></Reference><Reference><Citation>Talusan P., Bedri S., Yang S., Kattapuram T., Silva N., Roughley P.J., Stone J.R. Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry. Mol. Cell Proteom. 2005;4:1350&#x2013;1357. doi: 10.1074/mcp.M500088-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M500088-MCP200</ArticleId><ArticleId IdType="pmc">PMC1569481</ArticleId><ArticleId IdType="pubmed">15970583</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba H., Ishiwata T., Takashi E., Xu G., Asano G. Expression and localization of lumican in the ischemic and reperfused rat heart. Jpn. Circ. J. 2001;65:445&#x2013;450. doi: 10.1253/jcj.65.445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/jcj.65.445</ArticleId><ArticleId IdType="pubmed">11348051</ArticleId></ArticleIdList></Reference><Reference><Citation>Funderburgh J.L., Mitschler R.R., Funderburgh M.L., Roth M.R., Chapes S.K., Conrad G.W. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Investig. Ophthalmol. Vis. Sci. 1997;38:1159&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">9152235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Bowrin K., Hamad A.R., Chakravarti S. Extracellular Matrix Lumican Deposited on the Surface of Neutrophils Promotes Migration by Binding to &#x3b2;2 Integrin. J. Biol. Chem. 2009;284:23662&#x2013;23669. doi: 10.1074/jbc.M109.026229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.026229</ArticleId><ArticleId IdType="pmc">PMC2749141</ArticleId><ArticleId IdType="pubmed">19531489</ArticleId></ArticleIdList></Reference><Reference><Citation>Funderburgh J.L., Funderburgh M.L., Mann M.M., Conrad G.W. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J. Biol. Chem. 1991;266:24773&#x2013;24777. doi: 10.1016/S0021-9258(18)54296-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)54296-4</ArticleId><ArticleId IdType="pubmed">1761572</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;nnerfjord P., Heathfield T.F., Heineg&#xe5;rd D. Identification of Tyrosine Sulfation in Extracellular Leucine-rich Repeat Proteins Using Mass Spectrometry. J. Biol. Chem. 2004;279:26&#x2013;33. doi: 10.1074/jbc.M308689200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308689200</ArticleId><ArticleId IdType="pubmed">14551184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Hoffhines A.J., Moore K.L., Leary J.A. Determination of the sites of tyrosine O-sulfation in peptides and proteins. Nat. Methods. 2007;4:583&#x2013;588. doi: 10.1038/nmeth1056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth1056</ArticleId><ArticleId IdType="pubmed">17558413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubenek S., Nastase A., Niculescu A.M., Baila S., Herlea V., Lazar V., Paslaru L., Botezatu A., Tomescu D., Popescu I. Assessment of gene expression profiles in peripheral occlusive arterial disease. Can. J. Cardiol. 2012;28:712&#x2013;720. doi: 10.1016/j.cjca.2012.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2012.03.013</ArticleId><ArticleId IdType="pubmed">22721676</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng T., Liu Y., Gael A., Fu X., Deng X., Liu Y., Wu Y., Wu Y., Wang H., Deng Y., et al. Study on Proteomics-Based Aortic Dissection Molecular Markers Using iTRAQ Combined With Label Free Techniques. Front. Physiol. 2022;13:862732. doi: 10.3389/fphys.2022.862732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.862732</ArticleId><ArticleId IdType="pmc">PMC9335284</ArticleId><ArticleId IdType="pubmed">35910577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-W., Chou S.-H., Tung Y.-C., Hsiao F.-C., Ho C.-T., Chan Y.-H., Wu V.C.-C., Chou A.-H., Hsu M.-E., Lin P.-J., et al. Expression and role of lumican in acute aortic dissection: A human and mouse study. PLoS ONE. 2021;16:e0255238. doi: 10.1371/journal.pone.0255238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255238</ArticleId><ArticleId IdType="pmc">PMC8312931</ArticleId><ArticleId IdType="pubmed">34310653</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter S.Y., Collins J., Krastins B., Sarracino D., Lopez M., Losina E., Aliprantis A.O. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis. Arthritis Res. Ther. 2014;16:456. doi: 10.1186/s13075-014-0456-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-014-0456-6</ArticleId><ArticleId IdType="pmc">PMC4207325</ArticleId><ArticleId IdType="pubmed">25287745</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti G., Frikeche J., Lam C.Y.-M., Biswas A., Shinde V., Samanovic M., Kagan J.C., Mulligan M.J., Chakravarti S. Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis. Proc. Nat. Acad. Sci. USA. 2021;118:e2100999118. doi: 10.1073/pnas.2100999118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100999118</ArticleId><ArticleId IdType="pmc">PMC8271568</ArticleId><ArticleId IdType="pubmed">34215697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.Y., Pan Y.Y., Kopylov A.T., Zgoda V., Ma M.C., Wang C.H., Su W.C., Lai W.W., Cheng P.N., Liao P.C. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry. PROTEOMICS Clin. Appl. 2020;14:1900095. doi: 10.1002/prca.201900095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201900095</ArticleId><ArticleId IdType="pubmed">32012456</ArticleId></ArticleIdList></Reference><Reference><Citation>Corn P.G., Zhang M., Nogueras-Gonzalez G.M., Xiao L., Zurita A.J., Subudhi S.K., Tu S.-M., Aparicio A.M., Coarfa C., Rajapakshe K. A phase II study of cabozantinib and androgen ablation in patients with hormone-na&#xef;ve metastatic prostate cancer. Clin. Cancer Res. 2020;26:990&#x2013;999. doi: 10.1158/1078-0432.CCR-19-2389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-19-2389</ArticleId><ArticleId IdType="pubmed">31941830</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S., Chen R., Brand R.E., Hawley S., Tamura Y., Gafken P.R., Milless B.P., Goodlett D.R., Rush J., Brentnall T.A. Multiplex Targeted Proteomic Assay for Biomarker Detection in Plasma: A Pancreatic Cancer Biomarker Case Study. J. Proteome Res. 2012;11:1937&#x2013;1948. doi: 10.1021/pr201117w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr201117w</ArticleId><ArticleId IdType="pmc">PMC3292708</ArticleId><ArticleId IdType="pubmed">22316387</ArticleId></ArticleIdList></Reference><Reference><Citation>Murgia M., Brocca L., Monti E., Franchi M.V., Zwiebel M., Steigerwald S., Giacomello E., Sartori R., Zampieri S., Capovilla G., et al. Plasma proteome profiling of healthy subjects undergoing bed rest reveals unloading-dependent changes linked to muscle atrophy. J. Cachexia Sarcopenia Muscle. 2023;14:439&#x2013;451. doi: 10.1002/jcsm.13146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.13146</ArticleId><ArticleId IdType="pmc">PMC9891930</ArticleId><ArticleId IdType="pubmed">36517414</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Puente P., Mateos J., Fern&#xe1;ndez-Costa C., Oreiro N., Fern&#xe1;ndez-L&#xf3;pez C., Ruiz-Romero C., Blanco F.J. Identification of a Panel of Novel Serum Osteoarthritis Biomarkers. J. Proteome Res. 2011;10:5095&#x2013;5101. doi: 10.1021/pr200695p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr200695p</ArticleId><ArticleId IdType="pubmed">21973172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu M.-E., Cheng Y.-T., Chang C.-H., Chan Y.H., Wu V.C.-C., Hung K.-C., Lin C.-P., Liu K.-S., Chu P.-H., Chen S.-W. Level of serum soluble lumican and risks of perioperative complications in patients receiving aortic surgery. PLoS ONE. 2021;16:e0247340. doi: 10.1371/journal.pone.0247340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247340</ArticleId><ArticleId IdType="pmc">PMC7932520</ArticleId><ArticleId IdType="pubmed">33661915</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#x103;l&#x103;nescu A., Codreanu I.F., Comanici V.D., Stan I.V., B&#x103;l&#x103;nescu E., B&#x103;l&#x103;nescu P. Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study. BioMed Res. Int. 2020;2020:2102401. doi: 10.1155/2020/2102401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2102401</ArticleId><ArticleId IdType="pmc">PMC7448251</ArticleId><ArticleId IdType="pubmed">32879879</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue D., Li M., Xiang D., Sun J., Zhang W., Duan J., Cheng X., Wang C. Serum Proteomic Analysis by Nanoflow LC-MS/MS-Based Proteomics in IgA Chronic Kidney Disease. Clin. Lab. 2023;69 in press .</Citation><ArticleIdList><ArticleId IdType="pubmed">36912316</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasiou A., Tennstedt P., Wittig A., Huber R., Straub O., Schiess R., Steuber T. A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology. PLoS ONE. 2021;16:e0259093. doi: 10.1371/journal.pone.0259093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259093</ArticleId><ArticleId IdType="pmc">PMC8589165</ArticleId><ArticleId IdType="pubmed">34767586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Jiang H., Xu G., Chu N., Xu N., Wen H., Gu B., Liu J., Mao S., Na R., et al. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma. BioSci. Trends. 2016;10:210&#x2013;219. doi: 10.5582/bst.2016.01055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2016.01055</ArticleId><ArticleId IdType="pubmed">27319973</ArticleId></ArticleIdList></Reference><Reference><Citation>Appunni S., Anand V., Khandelwal M., Seth A., Mathur S., Sharma A. Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder. Tumor Biol. 2017;39:101042831769911. doi: 10.1177/1010428317699112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1010428317699112</ArticleId><ArticleId IdType="pubmed">28459201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahar T., Nigam A., Anjum S., Gupta N., Wajid S. Secretome Profiling and Computational Biology of Human Leiomyoma Samples Unravel Molecular Signatures with Potential for Diagnostic and Therapeutic Interventions. Reprod. Sci. 2021;28:2672&#x2013;2684. doi: 10.1007/s43032-021-00580-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-021-00580-9</ArticleId><ArticleId IdType="pubmed">33905083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.N., Park K.H., Ahn K., Im E.M., Oh E., Cho I. Extracellular matrix-related and serine protease proteins in the amniotic fluid of women with early preterm labor: Association with spontaneous preterm birth, intra-amniotic inflammation, and microbial invasion of the amniotic cavity. Am. J. Reprod. Immunol. 2023;90:e13736. doi: 10.1111/aji.13736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13736</ArticleId><ArticleId IdType="pubmed">37382175</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu T.-Y., Tsai K.-W., Lan K.-C., Hung H.-N., Lai Y.-J., Cheng H.-H., Tsai C.-C., Li S.-C. Identifying the potential protein biomarkers of preterm birth in amniotic fluid. Taiwan. J. Obstet. Gynecol. 2020;59:366&#x2013;371. doi: 10.1016/j.tjog.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tjog.2020.03.005</ArticleId><ArticleId IdType="pubmed">32416881</ArticleId></ArticleIdList></Reference><Reference><Citation>Shultz S.R., Shah A.D., Huang C., Dill L.K., Schittenhelm R.B., Morganti-Kossmann M.C., Semple B.D. Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury. J. Neuroinflamm. 2022;19:291. doi: 10.1186/s12974-022-02654-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02654-0</ArticleId><ArticleId IdType="pmc">PMC9730674</ArticleId><ArticleId IdType="pubmed">36482407</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson E., Liu C.Y., Chikama T., Hayashi Y., Kao C.W., Birk D.E., Funderburgh J.L., Jester J.V., Kao W.W. Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican. J. Biol. Chem. 2005;280:25541&#x2013;25547. doi: 10.1074/jbc.M500249200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500249200</ArticleId><ArticleId IdType="pmc">PMC2874675</ArticleId><ArticleId IdType="pubmed">15849191</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlevy J., Neame P.J., Vergnes J.P., Hassell J.R. Identification of the N-linked oligosaccharide sites in chick corneal lumican and keratocan that receive keratan sulfate. J. Biol. Chem. 1998;273:9615&#x2013;9621. doi: 10.1074/jbc.273.16.9615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.16.9615</ArticleId><ArticleId IdType="pubmed">9545293</ArticleId></ArticleIdList></Reference><Reference><Citation>Funderburgh J., Funderburgh M.L., Brown S.J., Vergnes J.P., Hassell J.R., Mann M.M., Conrad G.W. Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. J. Biol. Chem. 1993;268:11874&#x2013;11880. doi: 10.1016/S0021-9258(19)50281-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)50281-2</ArticleId><ArticleId IdType="pubmed">8099356</ArticleId></ArticleIdList></Reference><Reference><Citation>Krull N., Gressner A.M. Differential expression of keratan sulphate proteoglycans fibromodulin, lumican and aggrecan in normal and fibrotic rat liver. FEBS Lett. 1992;312:47&#x2013;52. doi: 10.1016/0014-5793(92)81407-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(92)81407-D</ArticleId><ArticleId IdType="pubmed">1385211</ArticleId></ArticleIdList></Reference><Reference><Citation>Funderburgh J. Keratan sulfate biosynthesis. IUBMB Life. 2002;54:187&#x2013;194. doi: 10.1080/15216540214932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15216540214932</ArticleId><ArticleId IdType="pmc">PMC2874674</ArticleId><ArticleId IdType="pubmed">12512857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlevy J., Beales M.P., Berryhill B.L., Cornuet P.K., Hassell J.R. Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. Exp. Eye Res. 2000;70:349&#x2013;362. doi: 10.1006/exer.1999.0789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exer.1999.0789</ArticleId><ArticleId IdType="pubmed">10712821</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B., Hutchison J.C., Hughes M.E., Kellogg D.R., Murray R.W. Electrical characterization of gel collected from shark electrosensors. Phys. Rev. E Stat. Nonlin Soft Matter Phys. 2002;65:061903. doi: 10.1103/PhysRevE.65.061903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevE.65.061903</ArticleId><ArticleId IdType="pubmed">12188755</ArticleId></ArticleIdList></Reference><Reference><Citation>Josberger E., Hassanzadeh P., Deng Y., Sohn J., Rego M.J., Amemiya C.T., Rolandi M. Proton conductivity in ampullae of Lorenzini jelly. Sci. Adv. 2016;2:e1600112. doi: 10.1126/sciadv.1600112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1600112</ArticleId><ArticleId IdType="pmc">PMC4928922</ArticleId><ArticleId IdType="pubmed">27386543</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J. Mucin-like glycopolymer gels in electrosensory tissues generate cues which direct electrolocation in amphibians and neuronal activation in mammals. Neural Regen. Res. 2019;14:1191&#x2013;1195. doi: 10.4103/1673-5374.251298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.251298</ArticleId><ArticleId IdType="pmc">PMC6425839</ArticleId><ArticleId IdType="pubmed">30804244</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J. Functional Consequences of Keratan Sulfate Sulfation in Electrosensory Tissues and in Neuronal Regulation. Adv. Biosyst. 2019;3:e1800327. doi: 10.1002/adbi.201800327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.201800327</ArticleId><ArticleId IdType="pubmed">32627425</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J. Keratan sulfate (KS)-proteoglycans and neuronal regulation in health and disease: The importance of KS-glycodynamics and interactive capability with neuroregulatory ligands. J. Neurochem. 2019;149:170&#x2013;194. doi: 10.1111/jnc.14652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14652</ArticleId><ArticleId IdType="pubmed">30578672</ArticleId></ArticleIdList></Reference><Reference><Citation>Manger P., Pettigrew J.D. Ultrastructure, number, distribution and innervation of electroreceptors and mechanoreceptors in the bill skin of the platypus, Ornithorhynchus anatinus. Brain Behav. Evol. 1996;48:27&#x2013;54. doi: 10.1159/000113185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000113185</ArticleId><ArticleId IdType="pubmed">8828862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields R., Fields K.D., Fields M.C. Semiconductor gel in shark sense organs? Neurosci. Lett. 2007;426:166&#x2013;170. doi: 10.1016/j.neulet.2007.08.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.08.064</ArticleId><ArticleId IdType="pmc">PMC2211453</ArticleId><ArticleId IdType="pubmed">17904741</ArticleId></ArticleIdList></Reference><Reference><Citation>Proske U., Gregory J.E., Iggo A. Sensory receptors in monotremes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998;353:1187&#x2013;1198. doi: 10.1098/rstb.1998.0275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.1998.0275</ArticleId><ArticleId IdType="pmc">PMC1692308</ArticleId><ArticleId IdType="pubmed">9720114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellono N., Leitch D.B., Julius D. Molecular tuning of electroreception in sharks and skates. Nature. 2018;558:122&#x2013;126. doi: 10.1038/s41586-018-0160-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0160-9</ArticleId><ArticleId IdType="pmc">PMC6101975</ArticleId><ArticleId IdType="pubmed">29849147</ArticleId></ArticleIdList></Reference><Reference><Citation>Haueisen M., Reis R.E. High resolution in turbid waters: Ampullae of lorenzini in the daggernose shark Carcharhinus oxyrhynchus (Valenciennes, 1839) (Elasmobranchii: Carcharhinidae) J. Fish Biol. 2023 doi: 10.1111/jfb.15583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfb.15583</ArticleId><ArticleId IdType="pubmed">37818861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Xia K., Lin L., Zhang F., Yu Y., St Ange K., Han X., Edsinger E., Sohn J., Linhardt R.J. Structural and Functional Components of the Skate Sensory Organ Ampullae of Lorenzini. ACS Chem. Biol. 2018;13:1677&#x2013;1685. doi: 10.1021/acschembio.8b00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00335</ArticleId><ArticleId IdType="pubmed">29708722</ArticleId></ArticleIdList></Reference><Reference><Citation>Selberg J., Jia M., Rolandi M. Proton conductivity of glycosaminoglycans. PLoS ONE. 2019;14:e0202713. doi: 10.1371/journal.pone.0202713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0202713</ArticleId><ArticleId IdType="pmc">PMC6407855</ArticleId><ArticleId IdType="pubmed">30849116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia M., Kim J., Nguyen T., Duong T., Rolandi M. Natural biopolymers as proton conductors in bioelectronics. Biopolymers. 2021;112:e23433. doi: 10.1002/bip.23433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.23433</ArticleId><ArticleId IdType="pubmed">34022064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallo F., Lagally G.M. Nano-origami: Art and function. Nanotoday. 2015;10:538&#x2013;541. doi: 10.1016/j.nantod.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nantod.2015.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J., Huang Y., Schmidt O.G., Gracias D.H. Origami MEMS and NEMS. MRS Bull. 2016;41:123&#x2013;129. doi: 10.1557/mrs.2016.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1557/mrs.2016.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Huang G., Zhao Z., Wang C., Cui J., Song E., Mei Y. Nanomembrane-assembled nanophotonics and optoelectronics: From materials to applications. J. Phys. Condens. Matter. 2023;35:093001. doi: 10.1088/1361-648X/acabf3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-648X/acabf3</ArticleId><ArticleId IdType="pubmed">36560918</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B., Zhang B., Wang L., Huang G., Mei Y. Tubular micro/nanomachines: From the basics to recent advances. Adv. Funct. Mater. 2017;28:1705872. doi: 10.1002/adfm.201705872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adfm.201705872</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Jiang B., Zhang Z., Ke S., Jin Y., Wen X., Ye C. A review of memristor: Material and structure design, device performance, applications and prospects. Sci. Technol. Adv. Mater. 2023;24:2162323. doi: 10.1080/14686996.2022.2162323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14686996.2022.2162323</ArticleId><ArticleId IdType="pmc">PMC9980037</ArticleId><ArticleId IdType="pubmed">36872944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L., Gao Z., Fu J., Ren W., Yang C., Wen J., Wan X., Ren Q., Gu S., Liu X., et al. Overview of Memristor-Based Neural Network Design and Applications. Front. Phys. 2022;10:839243. doi: 10.3389/fphy.2022.839243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphy.2022.839243</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterson B., Melrose J. Keratan sulfate, a complex glycosaminoglycan with unique functional capability. Glycobiology. 2018;28:182&#x2013;206. doi: 10.1093/glycob/cwy003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwy003</ArticleId><ArticleId IdType="pmc">PMC5993099</ArticleId><ArticleId IdType="pubmed">29340594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lwigale P. Corneal Development: Different Cells from a Common Progenitor. Prog. Mol. Biol. Transl. Sci. 2015;134:43&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">26310148</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwend T., Deaton R.J., Zhang Y., Caterson B., Conrad G.W. Corneal sulfated glycosaminoglycans and their effects on trigeminal nerve growth cone behavior in vitro: Roles for ECM in cornea innervation. Investig. Ophthalmol. Vis. Sci. 2012;53:8118&#x2013;8137. doi: 10.1167/iovs.12-10832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.12-10832</ArticleId><ArticleId IdType="pmc">PMC3522437</ArticleId><ArticleId IdType="pubmed">23132805</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad A., Conrad G.W. The keratocan gene is expressed in both ocular and non-ocular tissues during early chick development. Matrix Biol. 2003;22:323&#x2013;337. doi: 10.1016/S0945-053X(03)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0945-053X(03)00039-8</ArticleId><ArticleId IdType="pubmed">12935817</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Birk D.E., Hassell J.R., Kane B., Kao W.W. Keratocan-deficient mice display alterations in corneal structure. J. Biol. Chem. 2003;278:21672&#x2013;21677. doi: 10.1074/jbc.M301169200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301169200</ArticleId><ArticleId IdType="pubmed">12665512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes A., Melrose J. Immunolocalization of Keratan Sulfate in Rat Spinal Tissues Using the Keratanase Generated BKS-1(+) Neoepitope: Correlation of Expression Patterns with the Class II SLRPs, Lumican and Keratocan. Cells. 2020;9:826. doi: 10.3390/cells9040826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040826</ArticleId><ArticleId IdType="pmc">PMC7226845</ArticleId><ArticleId IdType="pubmed">32235499</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar S., Kerr B.C., Hayes A.J., Hughes C.E., Meek K.M., Caterson B. Immunochemical localization of keratan sulfate proteoglycans in cornea, sclera, and limbus using a keratanase-generated neoepitope monoclonal antibody. Investig. Ophthalmol. Vis. Sci. 2008;49:2424&#x2013;2431. doi: 10.1167/iovs.06-1498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.06-1498</ArticleId><ArticleId IdType="pubmed">18515583</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad A., Zhang Y., Tasheva E.S., Conrad G.W. Proteomic analysis of potential keratan sulfate, chondroitin sulfateA, and hyaluronic acid molecular interactions.Invest. Ophthalmol. Vis. Sci. 2010;51:4500&#x2013;4515. doi: 10.1167/iovs.09-4914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.09-4914</ArticleId><ArticleId IdType="pmc">PMC2941170</ArticleId><ArticleId IdType="pubmed">20375348</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J. Keratan Sulfate, An Electrosensory Neurosentient Bioresponsive Cell Instructive Glycosaminoglycan. Glycobiology. 2024:cwae014. doi: 10.1093/glycob/cwae014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwae014</ArticleId><ArticleId IdType="pmc">PMC10987296</ArticleId><ArticleId IdType="pubmed">38376199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabe K., Tateyama D., Toyoda H., Kawasaki N., Hashii N., Nakao H., Matsumoto S., Nonaka M., Matsumura H., Hirose Y., et al. A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures. Glycobiology. 2013;23:322&#x2013;336. doi: 10.1093/glycob/cws159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cws159</ArticleId><ArticleId IdType="pubmed">23154990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai Y., Nakao H., Kojima A., Komatsubara Y., Ohta Y., Kawasaki N., Kawasaki N., Toyoda H., Kawasaki T. Glycan Epitopes on 201B7 Human-Induced Pluripotent Stem Cells Using R-10G and R-17F Marker Antibodies. Biomolecules. 2021;11:508. doi: 10.3390/biom11040508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11040508</ArticleId><ArticleId IdType="pmc">PMC8065539</ArticleId><ArticleId IdType="pubmed">33805466</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H., Nagai Y., Kojima A., Kinoshita-Toyoda A. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells. Glycoconj. J. 2017;34:817&#x2013;823. doi: 10.1007/s10719-017-9801-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10719-017-9801-8</ArticleId><ArticleId IdType="pubmed">28980094</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder Z., Siu I.M., Eberhart C.G., Ap Rhys C., Bai R.Y., Staedtke V., Zhang H., Smoll N.R., Piantadosi S., Piccirillo S.G., et al. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. PLoS ONE. 2013;8:e75945. doi: 10.1371/journal.pone.0075945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075945</ArticleId><ArticleId IdType="pmc">PMC3797817</ArticleId><ArticleId IdType="pubmed">24146797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cait J., Hughes M.R., Zeglinski M.R., Chan A.W., Osterhof S., Scott R.W., Canals Hernaez D., Cait A., Vogl A.W., Bernatchez P., et al. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation. Proc. Natl. Acad. Sci. USA. 2019;116:4518&#x2013;4527. doi: 10.1073/pnas.1814766116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814766116</ArticleId><ArticleId IdType="pmc">PMC6410846</ArticleId><ArticleId IdType="pubmed">30787191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes A., Melrose J. Keratan Sulphate in the Tumour Environment. Adv. Exp. Med. Biol. 2020;1245:39&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32266652</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterson B., Christner J.E., Baker J.R. Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J. Biol. Chem. 1983;258:8848&#x2013;8854. doi: 10.1016/S0021-9258(18)32133-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)32133-1</ArticleId><ArticleId IdType="pubmed">6223038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehmet H., Scudder P., Tang P.W., Hounsell E.F., Caterson B., Feizi T. The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series. Eur. J. Biochem. 1986;157:385&#x2013;391. doi: 10.1111/j.1432-1033.1986.tb09680.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1986.tb09680.x</ArticleId><ArticleId IdType="pubmed">2423332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang P., Scudder P., Mehmet H., Hounsell E.F., Feizi T. Sulphate groups are involved in the antigenicity of keratan sulphate and mask i antigen expression on their poly-N-acetyllactosamine backbones. An immunochemical and chromatographic study of keratan sulphate oligosaccharides after desulphation or nitrosation. Eur. J. Biochem. 1986;160:537&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">2430799</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Chikada M., Yokoyama M.K., Kurokawa M.S., Ando T., Furukawa H., Arito M., Miyairi T., Kato T. Aberrant Glycosylation of Lumican in Aortic Valve Stenosis Revealed by Proteomic Analysis. Int. Heart J. 2016;57:104&#x2013;111. doi: 10.1536/ihj.15-252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.15-252</ArticleId><ArticleId IdType="pubmed">26742884</ArticleId></ArticleIdList></Reference><Reference><Citation>Imagama S., Sakamoto K., Tauchi R., Shinjo R., Ohgomori T., Ito Z., Zhang H., Nishida Y., Asami N., Takeshita S., et al. Keratan sulfate restricts neural plasticity after spinal cord injury. J. Neurosci. 2011;31:17091&#x2013;17102. doi: 10.1523/JNEUROSCI.5120-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5120-10.2011</ArticleId><ArticleId IdType="pmc">PMC6623845</ArticleId><ArticleId IdType="pubmed">22114278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Z., Sakamoto K., Imagama S., Matsuyama Y., Zhang H., Hirano K., Ando K., Yamashita T., Ishiguro N., Kadomatsu K. N-acetylglucosamine 6-O-sulfotransferase-1-deficient mice show better functional recovery after spinal cord injury. J. Neurosci. 2010;30:5937&#x2013;5947. doi: 10.1523/JNEUROSCI.2570-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2570-09.2010</ArticleId><ArticleId IdType="pmc">PMC6632605</ArticleId><ArticleId IdType="pubmed">20427653</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones L., Tuszynski M.H. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J. Neurosci. 2002;22:4611&#x2013;4624. doi: 10.1523/JNEUROSCI.22-11-04611.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-11-04611.2002</ArticleId><ArticleId IdType="pmc">PMC6758783</ArticleId><ArticleId IdType="pubmed">12040068</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui H., Ohgomori T., Natori T., Miyamoto K., Kusunoki S., Sakamoto K., Ishiguro N., Imagama S., Kadomatsu K. Keratan sulfate expression in microglia is diminished in the spinal cord in experimental autoimmune neuritis. Cell Death Dis. 2013;4:e946. doi: 10.1038/cddis.2013.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.479</ArticleId><ArticleId IdType="pmc">PMC3877550</ArticleId><ArticleId IdType="pubmed">24309933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R. Systematic reviews of treatment for inflammatory demyelinating neuropathy. J. Anat. 2002;200:331&#x2013;339. doi: 10.1046/j.1469-7580.2002.00041.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-7580.2002.00041.x</ArticleId><ArticleId IdType="pmc">PMC1570692</ArticleId><ArticleId IdType="pubmed">12090400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieseier B., Kiefer R., Gold R., Hemmer B., Willison H.J., Hartung H.P. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve. 2004;30:131&#x2013;156. doi: 10.1002/mus.20076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20076</ArticleId><ArticleId IdType="pubmed">15266629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhang Z.Y., Schluesener H.J. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J. Immunol. 2009;183:3081&#x2013;3091. doi: 10.4049/jimmunol.0901088.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901088</ArticleId><ArticleId IdType="pubmed">19675162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>